(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
最近の投稿
- 1
Four countries to boycott Eurovision 2026 over Israel’s inclusion - 27 Strange Apparatuses to Make Your Party Stick Out!
- 3Europe could get 42 more days of summer by the year 2100 due to climate change
- 4Florence's Uffizi Gallery moves treasures to safety after cyberattack
- 5Pick Your Top Method for starting the Morning
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- Three arrested in Paris after attempted bomb attack outside Bank of America
- Senegal limits foreign trips for officials as the fallout from Iran war deepens
- Everything you should know before booking a trip to Spain
- Shrapnel hits across central Israel, injuring several, causing property damage
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- Common ADHD medication prescribed in childhood may protect against risk of psychosis
- The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
